Cinnamon Toast Crunch | 36.15mg Per Tablet

Alkaloid Profile (Per Tablet)

Total Alkaloid Content: 36.15mg

7-Hydroxymitragynine: 87.87% (32.61mg)

Mitragynine Pseudoindoxyl: 2.50% (3.54mg)

Packaging Information

Packaging: White mylar

Single Pack: 5 tablets per pack

Multipack: 50 tablets per pack

Product Description

Cinnamon Toast Crunch is a high-strength tablet formulation crafted for experienced users seeking depth, balance, and long-lasting relief. Produced using an American-style press and a carefully layered alkaloid profile, this formulation delivers a smooth experience with a controlled onset and sustained effects.

The dominant concentration of 7-Hydroxymitragynine provides pronounced physical comfort and relaxation, while Mitragynine Pseudoindoxyl contributes stability and structure to the overall profile. 

Designed for reliability and consistency, Cinnamon Toast Crunch is well-suited for individuals managing persistent discomfort, high tolerance levels, or extended daily demands. Its balanced construction prioritizes effectiveness without sacrificing control, making it a dependable option for users who value strength paired with composure.

Caution & Responsible Use

This product is intended for established users. Due to its higher total alkaloid content and full-spectrum formulation, users should begin with a low amount and allow adequate time to assess individual response before considering additional use. Even experienced users are encouraged to approach this product with care to ensure a safe and controlled experience.

This product is not available for shipment to the following states: Alabama, Arkansas, Indiana, Rhode Island, Wisconsin, Florida; or the following counties: San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi), Ascension (Louisiana), Franklin (Louisiana), Ohio, and Rapides (Louisiana).

FDA Disclaimer:

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease.

Kratom products have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for safety, effectiveness, or as a treatment for any medical condition. The information provided on this website is for educational purposes only and should not be construed as medical advice. Kratom is not intended to diagnose, treat, cure, or prevent any disease.